2002
DOI: 10.1046/j.1365-2257.2002.00453.x
|View full text |Cite
|
Sign up to set email alerts
|

Systemic vasculitis complicating hairy cell leukaemia treatment with cladribine

Abstract: A single course of cladribine has been used commonly over the past decade to treat hairy cell leukaemia, with an impressive rate of complete remission and few serious adverse effects. Although vasculitis has been reported in the course of hairy cell leukaemia, it has only rarely been reported as the consequence of cladribine treatment. We describe a 73-year-old woman who developed serious systemic vasculitis with associated thrombocytopenia in the course of treatment with cladribine.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2003
2003
2020
2020

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 8 publications
(3 citation statements)
references
References 8 publications
0
3
0
Order By: Relevance
“…Treatment of the underlying HCL with either alpha-interferon or purine analogues may generally result in rapid improvement of the cutaneous scenario, up to complete regression of the vasculitic syndrome (7, 14, 15). A case of pharmacologically induced cutaneous manifestations in an HCL patient has also been described, as a consequence of the treatment of the disease itself (namely with cladribine) (16).…”
Section: Discussionmentioning
confidence: 99%
“…Treatment of the underlying HCL with either alpha-interferon or purine analogues may generally result in rapid improvement of the cutaneous scenario, up to complete regression of the vasculitic syndrome (7, 14, 15). A case of pharmacologically induced cutaneous manifestations in an HCL patient has also been described, as a consequence of the treatment of the disease itself (namely with cladribine) (16).…”
Section: Discussionmentioning
confidence: 99%
“…Production of cytokines including tumour necrosis factor-α, transforming growth factor-β and various paracrine growth factors by leukaemic cells possibly contributes to the latter. While some studies have related the production of autoantibodies by the polyclonal bystander B cells to autoimmune disease, others have implicated treatment with anticancer drugs (eg, purine analogues) that could lead to a loss of auto regulatory T cells 5 18. The role of neutropenia, impaired function of monocytes and macrophages and infiltration of the reticuloendothelial system by leukaemic hairy cells are other proposed mechanisms 2.…”
Section: Discussionmentioning
confidence: 99%
“…In particular, treatment with cladribine improves the cutaneous symptoms and complete regression of vasculitis was usually achieved [61,67,69,70,74]. On the other hand, cladribine itself can induce vasculitis in HCL patients [75,76].…”
Section: Vasculitis Syndromesmentioning
confidence: 99%